Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Menu, Eline" or (type any "bookEditor journalEditor issueEditor" and editor="Menu, Eline")

Add to list
- Journal Article
- A1
- open access
Pyrroline-5-carboxylate reductase 1 : a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis

Inge Oudaert, Hatice Satilmis, Philip Vlummens (UGent) , Wouter De Brouwer, Anke Maes, Dirk Hose, Elke De Bruyne, Bart Ghesquiere, Karin Vanderkerken, Kim De Veirman, et al.

(2022) JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 41(1).
Add to list
- Journal Article
- A1
- open access
The use of murine models for studying mechanistic insights of genomic instability in multiple myeloma

Philip Vlummens (UGent) , Kim De Veirman, Eline Menu, Elke De Bruyne, Fritz Offner (UGent) , Karin Vanderkerken and Ken Maes

(2019) FRONTIERS IN GENETICS. 10.
Add to list
- Journal Article
- A1
- open access
Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma

Anke Maes, Ken Maes, Philip Vlummens (UGent) , Hendrik De Raeve, Julie Devin, Vanessa Szablewski, Kim De Veirman, Eline Menu, Jerome Moreaux, Karin Vanderkerken, et al.

(2019) BLOOD CANCER JOURNAL. 9.
Add to list
- Journal Article
- A1
- open access
The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma

Sylvia Faict, Inge Oudaert, Ludovic D'Auria, Jonas Dehairs, Ken Maes, Philip Vlummens (UGent) , Kim De Veirman, Elke De Bruyne, Karel Fostier, Isabelle Vande Broek, et al.

(2019) CANCERS. 11(12).
Add to list
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

Kim De Veirman, Eline Menu, Ken Maes, Nathan De Beule, Eva De Smedt, Anke Maes, Philip Vlummens (UGent) , Karel Fostier, Alboukadel Kassambara, Jerome Moreaux, et al.

(2019) CANCER LETTERS. 442. p.233-241
Add to list
- Conference Paper
- C3
The exosomal transfer of acid sphingomyelinase contributes to drug resistance in multiple myeloma

Inge Oudaert, Sylvia Faict, Ludovic D'Auria, Jonas Dehairs, Ken Maes, Philip Vlummens (UGent) , Lotte Jacobs, Kim De Veirman, Elke De Bruyne, Karel Fostier, et al.

(2019) BLOOD. 134.
Add to list
- Journal Article
- A1
- open access
The anaphase-promoting complex/cyclosome : a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma

Anke Maes, Ken Maes, Hendrik De Raeve, Eva De Smedt, Philip Vlummens (UGent) , Vanessa Szablewski, Julie Devin, Sylvia Faict, Kim De Veirman, Eline Menu, et al.

(2019) BRITISH JOURNAL OF CANCER. 120(12). p.1137-1146
Add to list
Checkpoint inhibition in the treatment of multiple myeloma : a way to boost innate-like T cell anti-tumor function?

Koen Venken (UGent) , Mérédis Favreau (UGent) , Djoere Gaublomme (UGent) , Eline Menu, Karin Vanderkerken and Dirk Elewaut (UGent)

(2018) MOLECULAR IMMUNOLOGY. 101. p.521-526
Add to list
- Journal Article
- A1
- open access
Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition

Mérédis Favreau (UGent) , Koen Venken (UGent) , Sylvia Faict, Ken Maes, Kim De Veirman, Elke De Bruyne, Xavier Leleu, Louis Boon, Dirk Elewaut (UGent) , Karin Vanderkerken, et al.

(2017) HAEMATOLOGICA. 102(7). p.E266-E270
Add to list
- Journal Article
- A1
- open access
Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells

Nathan De Beule, Eline Menu, Mathieu Bertrand (UGent) , Mérédis Favreau (UGent) , Elke De Bruyne, Ken Maes, Kim De Veirman, Magdalena Radwanska (UGent) , Afshin Samali, Stefan Magez (UGent) , et al.

(2017) ONCOTARGET. 8(32). p.52016-52025

Academic Bibliography

Pyrroline-5-carboxylate reductase 1 : a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis

The use of murine models for studying mechanistic insights of genomic instability in multiple myeloma

Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma

The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma

Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway

The exosomal transfer of acid sphingomyelinase contributes to drug resistance in multiple myeloma

The anaphase-promoting complex/cyclosome : a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma

Checkpoint inhibition in the treatment of multiple myeloma : a way to boost innate-like T cell anti-tumor function?

Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition

Experimental African trypanosome infection suppresses the development of multiple myeloma in mice by inducing intrinsic apoptosis of malignant plasma cells

Contents

Support

Contact